FDA Inspection
Taizhou Taifa Pharmaceuticals Co., Ltd.Taizhou Taifa Pharmaceuticals Co., Ltd. – FDA Inspection, May 15, 2019
Record Details
This FDA Inspection record concerns Taizhou Taifa Pharmaceuticals Co., Ltd., with an inspection on May 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 36b71010-c8c3-4145-b1ac-4570c589c2a9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1094254
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Taizhou Taifa Pharmaceuticals Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taizhou Taifa Pharmaceuticals Co., Ltd.
- FDA Inspection 990107 - 2016-09-15
- FDA Inspection 883252 - 2014-05-15
- FDA Inspection 676458 - 2010-08-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.